In this study, we investigated the potential of an optimised finger-prick blood collection approach for remote quantification of NfL in a multi-disease discovery cohort of four different neurological conditions (HD, MS, ALS, PD) via a series of experiments that directly compared the impact of the collection method, processed sample type, and delayed processing on analyte concentrations. The gene discussed is NEFL; the disease is myeloid sarcoma.